Posted by Two Blokes
Zacks.com users have recently been watching Robinhood Markets (HOOD) quite a bit. Thus, it is worth knowing th
Source: Two Blokes Trading
Posted by Two Blokes
Kinder Morgan (KMI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise t
Source: Two Blokes Trading
Posted by Two Blokes
Regeneron Pharmaceuticals will acquire 23andMe's assets for $256 million, both companies said. 23andMe filed f
Source: Two Blokes Trading
Posted by Two Blokes
Moody's downgraded U.S. debt one notch on Friday, joining S&P and Fitch in negatively assessing U.S.
Source: Two Blokes Trading
Posted by Two Blokes
CHOW TAI FOOK (CJEWY) made it through our "Recent Price Strength" screen and could be a great choice for inves
Source: Two Blokes Trading
Posted by Two Blokes
Legacy Education Inc. (LGCY) made it through our "Recent Price Strength" screen and could be a great choice fo
Source: Two Blokes Trading
Posted by Two Blokes
Capcom (CCOEY) made it through our "Recent Price Strength" screen and could be a great choice for investors lo
Source: Two Blokes Trading
Posted by Two Blokes
Kemper (KMPR) could be a great choice for investors looking to buy stocks that have gained strong momentum rec
Source: Two Blokes Trading
Posted by Two Blokes
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable pr
Source: Two Blokes Trading
Posted by Two Blokes
The numbers say one thing. The guidance says another.
Source: Two Blokes Trading
Posted by Two Blokes
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has agreed to buy genetic testing company 23andMe for $256 million
Source: Two Blokes Trading
Posted by Two Blokes
Strategy (NASDAQ: MSTR) stock climbed $4,78 (1,20%) from its latest closing price of $399.80 to its Monday pri
Source: Two Blokes Trading